BMS’ Breyanzi Beats COVID-19 Constraints, Emerges As First RMAT Approval

 
• By Bridget Silverman
  
BMS is giving itself a high five after the Breyanzi approval.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews